Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00958451 · ClinicalTrials.gov registry record · Phase 4
Vitamin D Deficiency in Chronic Kidney Disease (CKD) Patients
A Phase 4 study, sponsored by Salem Veterans Affairs Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 80
- Enrollment target
NCT00958451 is a Phase 4 study that has completed, run by Salem Veterans Affairs Medical Center. The registered enrollment target is 80 participants.
The verdict
NCT00958451, a Phase 4 study, has completed, sponsored by Salem Veterans Affairs Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 80 participants
- Enrollment target
Study Summary
This is an open label, single center, randomized, active comparator controlled study, comparing the effects of vitamin D replacement using oral ergocalciferol versus paricalcitol on parathyroid hormone (PTH) levels in patients with stage 3 and 4 CKD and vitamin D deficiency or insufficiency. The purpose of this study is to determine which of these two approaches is more successful.
Interventions
- DRUG Paricalcitol
- DRUG Ergocalciferol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2009-07 |
| Est. Completion | 2011-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00958451
The ClinicalTrials.gov registry entry for NCT00958451 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Salem Veterans Affairs Medical Center, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Paricalcitol is the first listed.
NCT00958451 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00958451 about?
NCT00958451 is a clinical study titled "Vitamin D Deficiency in Chronic Kidney Disease (CKD) Patients". This is an open label, single center, randomized, active comparator controlled study, comparing the effects of vitamin D replacement using oral ergocalciferol versus paricalcitol on parathyroid hormone (PTH) levels in patients with stage 3 and 4 CKD and vitamin D deficiency or insufficiency. The pur...
What is the current status of trial NCT00958451?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 80 participants. The study started on 2009-07. Estimated completion is 2011-01.
What interventions are being tested in trial NCT00958451?
The interventions under investigation include: Paricalcitol (DRUG), Ergocalciferol (DRUG).
Who is sponsoring clinical trial NCT00958451?
This trial is sponsored by Salem Veterans Affairs Medical Center, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.